Prevalence of Overweight and Obesity among Iranian School Children in Different Ethnicities

Seyed-Jalil Mirmohammadi1, Rahmatollah Hafezi, Amir Houshang Mehrparvar

  • 1Department of Occupational Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.

Insights

Childhood overweight and obesity are significant health issues. This study found ethnic variations in body mass index (BMI) among Iranian children, with higher prevalence in boys.

Area of Science:

  • Pediatric Endocrinology
  • Public Health Nutrition
  • Anthropometry

Background:

  • Childhood overweight and obesity represent critical global health challenges with long-term implications.
  • Prevalence rates of overweight and obesity exhibit variability across different racial groups, sexes, and geographic regions.

Purpose of the Study:

  • To investigate the prevalence and distribution of overweight and obesity among Iranian children aged 7-18 years.
  • To examine the influence of ethnicity, gender, and age on body mass index (BMI) in this pediatric population.

Main Methods:

  • A cross-sectional study involving 30,092 Iranian children from six distinct ethnic groups, selected via cluster sampling.
  • Measurement of body mass index (BMI) and assessment of overweight and obesity prevalence using Iranian and International Obesity Task Force (IOTF) standards.
  • Analysis of BMI distribution based on gender, age, and ethnic background.

Main Results:

  • A statistically significant variation in BMI was observed across different ethnic groups.
  • The overall prevalence of overweight and obesity in Iranian children was 9.27% and 3.22%, respectively, when compared to international benchmarks.
  • Overweight and obesity were found to be more frequent among boys compared to girls.

Conclusions:

  • Significant ethnic disparities exist in the body mass index (BMI) of Iranian children.
  • These findings underscore the importance of considering ethnic and gender factors in addressing childhood overweight and obesity in Iran.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Surveys02:16

Surveys

Often, psychologists develop surveys as a means of gathering data. Surveys are lists of questions to be answered by research participants, and can be delivered as paper-and-pencil questionnaires, administered electronically, or conducted verbally. Generally, the survey itself can be completed in a short time, and the ease of administering a survey makes it easy to collect data from a large number of people.
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...